Internal Medicine, Infectious Disease · Tyler, TX
NPI
1376543546
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
935 S Baxter Ave, Ste 103
Tyler, TX, 75701
Phone (903) 592-4473
Groups this clinician bills Medicare through
Medicare paid, 2024
$165K
2,289 services
Medicare patients, 2024
317
Average age 72
Drug cost, 2024
$1.6M
1,445 prescriptions
Company payments, 2025
$233
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven L Hickerson was code 99232 (hospital e&m - subsequent), 1,474 times for 267 patients. In total Steven L Hickerson billed 2,289 services in 15 codes, and Medicare paid $165K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,474 | 267 | $59.97 | $88K |
| 99233 Hospital E&M - Subsequent | Facility | 274 | 117 | $90.83 | $25K |
| 99223 Hospital E&M - Initial | Facility | 136 | 127 | $132.61 | $18K |
| 99222 Hospital E&M - Initial | Facility | 132 | 123 | $99.84 | $13K |
| 99213 Office E&M - Established | Office | 120 | 59 | $64.59 | $7,751 |
| 99214 Office E&M - Established | Office | 109 | 56 | $94.26 | $10K |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 19 | $38.04 | $799 |
By year: 2022 $148K for 2,026 services; 2023 $204K for 2,670 services; 2024 $165K for 2,289 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven L Hickerson prescribed most often to Medicare patients was Daptomycin, with 154 prescriptions and refills. In total Steven L Hickerson wrote 1,445 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 154 | 154 | 28 | $61K |
| Ceftriaxone Ceftriaxone Sodium | 92 | 92 | 25 | $5,031 |
| Tivicay Dolutegravir Sodium | 87 | 87 | 11 | $248K |
| Cefazolin Sodium Generic | 81 | 81 | 20 | $5,350 |
| Descovy Emtricitabine/Tenofov Alafenam | 77 | 83 | Under 11 | $191K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 73 | 79 | 16 | $313K |
| Prezcobix Darunavir/Cobicistat | 58 | 58 | Under 11 | $162K |
| Cefepime Hcl Generic | 53 | 53 | 15 | $8,769 |
| Cephalexin Generic | 50 | 58 | 20 | $1,176 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 59 | 12 | $810 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 37 | 37 | Under 11 | $183K |
| Atorvastatin Calcium Generic | 32 | 46 | Under 11 | $307 |
| Doxycycline Hyclate Generic | 31 | 31 | 13 | $847 |
| Juluca Dolutegravir/Rilpivirine | 27 | 27 | Under 11 | $101K |
| Fluconazole Generic | 26 | 26 | Under 11 | $1,943 |
Brand drugs: 448 claims; generic drugs: 997 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven L Hickerson $233 ($233 in general payments such as food, travel and fees) from 2 companies. The largest payer was Merck Sharp & Dohme LLC with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.